用复合RSV预溢F蛋白进行鼻内免疫的粘膜辅助剂的比较评估

Hongqiao Hu1, Lei Cao1, Jie Jiang1

  • 1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, NHC Key Laboratory of Medical Virology and Viral Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Vaccines
|February 26, 2026
PubMed
概括

优化鼻内呼吸道同胞性病毒 (RSV) 疫苗需要仔细选择辅助剂和剂量. 低至中等剂量的CpG-ODN (10微克) 有望对抗RSV有效的粘膜免疫.